Biocity Biopharmaceutics Co., Ltd.

(Business location: 24th Floor, No. 581, Jianshe West Road, Wuxi)Room 315, No. 88, Meiliang Road, Mashan, Binhu District, Wuxi, 江苏省, China

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

81.8%

Phase 2

9.1%

Phase 3

9.1%

Trial Status Distribution

Active, not recruiting

9.1%

Not yet recruiting

18.2%

Recruiting

72.7%

Clinical Trials

Trials sponsored by this organization (11)

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1

Recruiting

interventional

Mar 2026111 participants

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

Phase 1

Recruiting

interventional

Nov 2025180 participants

A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria

Phase 3

Recruiting

interventional

Feb 2025360 participants

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

Phase 1

Recruiting

interventional

Jun 2024148 participants

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

Phase 1

Not yet recruiting

interventional

Oct 2023112 participants

BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma

Phase 1

Not yet recruiting

interventional

Oct 202383 participants

A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML

Phase 1

Recruiting

interventional

Jul 202313 participants

Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors

Phase 1

Recruiting

interventional

Jun 202327 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations